Style | Citing Format |
---|---|
MLA | Maleknia M, et al.. "Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis." Molecular Biology Reports, vol. 47, no. 6, 2020, pp. 4767-4778. |
APA | Maleknia M, Shahrabi S, Ghanavat M, Vosoughi T, Saki N (2020). Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis. Molecular Biology Reports, 47(6), 4767-4778. |
Chicago | Maleknia M, Shahrabi S, Ghanavat M, Vosoughi T, Saki N. "Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis." Molecular Biology Reports 47, no. 6 (2020): 4767-4778. |
Harvard | Maleknia M et al. (2020) 'Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis', Molecular Biology Reports, 47(6), pp. 4767-4778. |
Vancouver | Maleknia M, Shahrabi S, Ghanavat M, Vosoughi T, Saki N. Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis. Molecular Biology Reports. 2020;47(6):4767-4778. |
BibTex | @article{ author = {Maleknia M and Shahrabi S and Ghanavat M and Vosoughi T and Saki N}, title = {Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis}, journal = {Molecular Biology Reports}, volume = {47}, number = {6}, pages = {4767-4778}, year = {2020} } |
RIS | TY - JOUR AU - Maleknia M AU - Shahrabi S AU - Ghanavat M AU - Vosoughi T AU - Saki N TI - Essential Thrombocythemia: A Hemostatic View of Thrombogenic Risk Factors and Prognosis JO - Molecular Biology Reports VL - 47 IS - 6 SP - 4767 EP - 4778 PY - 2020 ER - |